Fig 1.
Kaplan-Meier estimates of overall survival probability by treatment regimen. F, fludarabine; FC, fludarabine and cyclophosphamide; FM, fludarabine and mitoxantrone; FCR, fludarabine, cyclophosphamide, and rituximab; OS, overall survival.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.